16-25140239-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016309.3(LCMT1):c.396C>G(p.His132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000319 in 1,597,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016309.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCMT1 | ENST00000399069.8 | c.396C>G | p.His132Gln | missense_variant | Exon 4 of 11 | 1 | NM_016309.3 | ENSP00000382021.3 | ||
LCMT1 | ENST00000380962.9 | n.*253C>G | non_coding_transcript_exon_variant | Exon 5 of 12 | 2 | ENSP00000370349.5 | ||||
LCMT1 | ENST00000380962.9 | n.*253C>G | 3_prime_UTR_variant | Exon 5 of 12 | 2 | ENSP00000370349.5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000314 AC: 7AN: 222616 AF XY: 0.0000418 show subpopulations
GnomAD4 exome AF: 0.0000311 AC: 45AN: 1445050Hom.: 0 Cov.: 29 AF XY: 0.0000293 AC XY: 21AN XY: 717208 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74338 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.396C>G (p.H132Q) alteration is located in exon 4 (coding exon 4) of the LCMT1 gene. This alteration results from a C to G substitution at nucleotide position 396, causing the histidine (H) at amino acid position 132 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at